Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2014
11/13/2014US20140336129 Targeting the EGFR-SGLT1 Interaction for Cancer Therapy
11/13/2014US20140336120 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury
11/13/2014US20140336112 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
11/13/2014US20140336111 Therapeutic Use of Activators of Zinc Finger Protein GL13
11/13/2014US20140336107 Glp-1 receptor agonist peptide gastrin conjugates
11/13/2014US20140335208 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells
11/13/2014US20140335191 Compositions and methods for enhancing brain function
11/13/2014US20140335183 Wound healing profile
11/13/2014US20140335170 Reduced Mass Metformin Formulations
11/13/2014US20140335168 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
11/13/2014US20140335161 Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers
11/13/2014US20140335160 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same
11/13/2014US20140335159 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same
11/13/2014US20140335154 Methods and formulations to achieve tumor targeted double stranded rna mediated cell death
11/13/2014US20140335134 Method for treating urinary system disorders
11/13/2014US20140335132 Binding drugs with nanocrystalline cellulose (ncc)
11/13/2014US20140335123 Food Composition and Uses for Diabetes
11/13/2014US20140335106 Methods and pharmaceutical compositions for treating cancer
11/13/2014US20140335091 Anti-glucagon receptor antibodies and methods of use thereof
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/13/2014US20140335083 Methods of treatment and prevention of eye diseases
11/13/2014US20140335082 Combination therapy comprising an mmp-14 binding protein
11/13/2014US20140335080 Ester derivatives of androgen receptor modulators and methods for their use
11/13/2014US20140335079 Solenopsin and derivatives, therapeutic compositions, and methods related thereto
11/13/2014US20140335078 Use Of Complement Inhibitors To Treat Ocular Diseases
11/13/2014US20140335074 Methods for improving medical therapies
11/13/2014US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
11/13/2014US20140335050 Methods, compositions, and kits for the treatment of cancer
11/13/2014US20140335048 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, Salts Thereof and Methods of Using the Same in Combination Therapy
11/13/2014US20140335022 Method for patient selection
11/13/2014US20140335018 Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
11/13/2014US20140335014 Il-1 alpha dual variable domain immunoglobulins and uses thereof
11/11/2014US8884030 Inhibitors of Flaviviridae viruses
11/11/2014US8883858 Small molecule xanthine oxidase inhibitors and methods of use
11/11/2014US8883857 Small molecule xanthine oxidase inhibitors and methods of use
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883847 Compositions and methods of treatment using modulators of motoneuron diseases
11/11/2014US8883844 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
11/11/2014US8883832 Compounds, compositions, and methods for preventing metastasis of cancer cells
11/11/2014US8883830 Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
11/11/2014US8883823 Crystalline forms of a prolyl hydroxylase inhibitor
11/11/2014US8883821 Substituted pyrazolo[3,4-b]pyridines as medicaments
11/11/2014US8883819 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
11/11/2014US8883817 Combination analgesic employing opioid and neutral antagonist
11/11/2014US8883812 Piperidinyl pyrimidine amides as Kv7 potassium channel openers
11/11/2014US8883801 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
11/11/2014US8883800 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/11/2014US8883771 Bivalent inhibitors of IAP proteins and therapeutic methods using the same
11/11/2014US8883770 Synthetic bile acid compositions and methods
11/11/2014US8883765 Anti-cytomegalovirus activity of artemisinin-derived dimers
11/11/2014US8883759 Anti-tumor effect potentiator
11/11/2014US8883758 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
11/11/2014US8883757 Compositions and methods for treatment of ovarian cancer
11/11/2014US8883750 Method of treating diabetes
11/11/2014US8883747 Topical antifungal compositions and methods of use thereof
11/11/2014US8883743 Methods for treating obesity employing an SGLT2 inhibitor
11/11/2014US8883737 Methods of treating cancer
11/11/2014US8883736 Compositions and methods for treating and diagnosing cancer
11/11/2014US8883721 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
11/11/2014US8883217 Modified release formulations containing drug-ion exchange resin complexes
11/11/2014US8883216 Methods and ceramic nanoparticle compositions for heavy metal removal and for oral delivery of desirable agents
11/11/2014US8883194 Adsorbent-containing hemostatic devices
11/11/2014US8883184 Methods and compositions for regenerating connective tissue
11/11/2014US8883182 Method and material for enhanced tissue-biomaterial integration
11/11/2014US8883174 Compositions for stimulation of mammalian innate immune resistance to pathogens
11/11/2014US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
11/11/2014US8883138 Adiponectin production accelerating composition
11/11/2014US8883136 Methods for accelerating the healing of connective tissues injuries and disorders
11/11/2014US8883135 Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
11/11/2014US8882075 Furnace mount
11/06/2014US20140330252 Biomatrix structural containment and fixation systems and methods of use thereof
11/06/2014US20140330192 Dressing for application to a wound or burn
11/06/2014US20140329908 Method For The Treatment of Dravet Syndrome
11/06/2014US20140329905 Histone deacetylase 10-inhibitor co-treatment in cancer
11/06/2014US20140329901 Compounds for treatment of cell proliferative diseases
11/06/2014US20140329879 Diagnosis and treatment of taxane-resistant cancers
11/06/2014US20140329868 Methods for treating hypertension
11/06/2014US20140329867 Inhibitors of notch signalling pathway and use thereof in treatment of cancers
11/06/2014US20140329856 Method of treating pain
11/06/2014US20140329845 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
11/06/2014US20140329844 Method of restoring the incretin effect
11/06/2014US20140329839 New Crystalline Form of Pemirolast
11/06/2014US20140329833 Lysine demethylase inhibitors for inflammatory diseases or conditions
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140329793 Pharmaceutical compositions and uses thereof
11/06/2014US20140329777 Methods to treat infections
11/06/2014US20140329776 Mitochondria-Targeted Antioxidants for Treatment of Age-Related Brain Disorders
11/06/2014US20140329756 Temperature-release catalyst for cross-linking halyuronic acid during injection
11/06/2014US20140329747 Compositions and Methods for Treating Renal Failure
11/06/2014US20140328948 Buffered compositions for dialysis
11/06/2014US20140328933 Novel formulations and methods
11/06/2014US20140328932 Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity
11/06/2014US20140328931 Nucleic acid particles, methods and use thereof
11/06/2014US20140328929 Method of Preventing Acute Graft-Versus-Host Disease using Oral Beclomethasone Dipropionate
11/06/2014US20140328926 Modified hyaluronic acid polymer compositions and related methods
11/06/2014US20140328924 Delivery of immunosuppressants having a specified pharmacodynamic effective-life and antigen for the induction of immune tolerance
11/06/2014US20140328919 Polymer-agent conjugates, particles, compositions, and related methods of use
11/06/2014US20140328913 Rapidly disintegrating gelatinous coated tablets
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 1151